CSPC Pharmaceutical Group's Independently Developed SYS6055 Txhaj Tau Txais Kev Pom Zoo Kev Pom Zoo los ntawm National Medical Products Administration (NMPA)

CSPC Pharmaceutical Group's Independently Developed SYS6055 Injection Obtained An Implied Clinical Trial Approval From The National Medical Products Administration (NMPA)

Thaum Lub Ib Hlis 29th, CSPC Pharmaceutical Group tus kheej tsim "SYS6055 Txhaj" tau txais kev pom zoo los ntawm Lub Tsev Haujlwm Saib Xyuas Kev Kho Mob Hauv Tebchaws (NMPA), tus lej lees paub: CXSL2500947. Qhov no yog thawj zaug hauv vivo CAR-T kev kho mob tau pom zoo rau kev siv tshuaj hauv Suav teb, qhia txog kev rov ua dua / rov ua dua tshiab B-cell lymphomat !

HYQURE muab txoj haujlwm no nrog cov kev pabcuam kuaj biosafety raws li cov qauv thoob ntiaj teb, suav nrog Cell Line Characterization thiab Replication -Competent Lentivirus (RCL) testing. Leveraging thoob ntiaj teb kev ua tau zoo thiab kev ua haujlwm, kev xa khoom sai, thiab kev tswj xyuas qhov project, peb tiv thaiv kev tshaj tawm thiab kev nthuav dav thoob ntiaj teb ntawm kev kho tshiab.

Hais txog CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited tau tsim nyob rau hauv 1997. Txhawb nqa lub hom phiaj ntawm "Tsim cov tshuaj zoo rau Tuam Tshoj, Pab neeg thoob ntiaj teb," cov pab pawg tau tuav ob npaug -tus lej loj hlob hauv cov cim kev ua haujlwm tseem ceeb hauv lub xyoo dhau los ntawm kev tsim kho tshiab- tau tsav txoj kev loj hlob. Tam sim no tau hloov mus rau hauv kev lag luam tshiab thoob ntiaj teb nrog 28,000 tus neeg ua haujlwm. Nws Hong Kong- teev npe chaw ua haujlwm (01093. HK) yog ib qho tseem ceeb ntawm Hang Seng Index thiab nyob qib 19th thoob ntiaj teb hauv cov kws tshuaj R & D pipeline scale qeb, sawv cev rau Suav cov tuam txhab tshuaj hauv kev pabcuam cov neeg mob thoob ntiaj teb.

Raws li kev txheeb cais tsis tiav, HYQURE tau ua tiav kev txhawb nqa ntau dua 130 txoj haujlwm hauv kev tau txais kev pom zoo hauv kev soj ntsuam thiab kev lag luam los ntawm nws cov kev pabcuam kuaj biosafety thoob ntiaj teb (suav nrog ntau dua 60 qhov kev xa tawm thoob ntiaj teb). Lub tuam txhab tau muab kev txhawb nqa tseem ceeb rau ntau dua 60 BLA (Biologics License Application) thiab cov haujlwm ua lag luam. Cov peev txheej ntawm cov phiaj xwm xa tawm dav dav suav nrog ntau pawg, suav nrog ADC cov tshuaj, mono-/bi-/multi-cov tshuaj tiv thaiv tshwj xeeb, cov protein sib txuas, CAR-T / CAR-NK kev kho mob, iPSC/MSC cell therapies, {0} kho cov noob caj noob ces,

Xa kev nug